Comments: NJ A2488 | 2020-2021 | Regular Session

Bill Title: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Spectrum: Moderate Partisan Bill (Democrat 4-1)

Status: (Introduced - Dead) 2020-02-03 - Introduced, Referred to Assembly Health Committee [A2488 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2020 New Jersey A2488 at this time.

Social Comments on NJ A2488

feedback